The University of Chicago Header Logo

Connection

Marina Chiara Garassino to Deoxycytidine

This is a "connection" page, showing publications Marina Chiara Garassino has written about Deoxycytidine.
Connection Strength

0.185
  1. Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Oncol. 2021 10; 22(10):1438-1447.
    View in: PubMed
    Score: 0.185
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.